Reports
The following list of reports reflects the latest in findings and outcomes in medical research as presented at major medical meetings and published peer-reviewed medical journals. In this section you can view reports from important congresses as well as summaries of some recently published journal articles. Please let us know if you have a particular area of interest you would like to see covered.
Canadian Cardiovascular Congress
Improving Outcomes with Antiplatelet Therapy: Practical Applications from New Research
Toronto, Ontario / October 25-29, 2008
Toronto - Most patients with ST-segment elevation myocardial infarction (STEMI) or high-risk non-STEMI (NSTEMI) should receive dual antiplatelet therapy on presentation, although a sizeable proportion of them still do not. Even if optimally...
Canadian Cardiovascular Congress
Landmark Trial Reinvigorates Treatment Options for Patients with Atrial Fibrillation
Toronto, Ontario / October 25-29, 2008
Toronto -In Canada, no new antiarrhythmic strategies have emerged over the past 20 years for the treatment of atrial fibrillation(AF), leaving a large unmet need for tremendous numbers of patients. This is especially true for those with...
Canadian Cardiovascular Congress
Addressing Care Gaps in Acute Coronary Syndromes
Toronto, Ontario / October 25-29, 2008
Which STEMI Patients to Transfer?Development of systems of care for STEMI has been a major research focus over the last several years, remarked Dr. Robert Welsh, Associate Professor of Medicine and Co-Director,University of Alberta Chest...
PHYSICIAN PERSPECTIVE - Based on presentations during the 61st Annual Meeting of the Canadian Cardiovascular Congress
Update on the Management of Atrial Fibrillation
Toronto, Ontario / October 25-29, 2008
Reviewed and edited by: Denis Roy, MD Montreal Heart Institute, Professor and Chair, Department of Medicine, Université de Montréal, Montreal, Quebec Atrial fibrillation (AF) may emerge at any point along the...
Canadian Cardiovascular Congress
Attenuating Cardiometabolic Risk: Expert Opinion Debate on Lifestyle Changes vs. Pharmacotherapy
Toronto, Ontario / October 25-29, 2008
Toronto - Even for patients who receive optimal prevention strategies, residual cardiovascular (CV) disease risk remains at least partly due to intra-abdominal obesity and accompanying metabolic abnormalities. Reducing cardiometabolic risk...
Canadian Cardiovascular Congress
Cardiovascular Risk Prediction and Protection: Singling out High-risk Groups
Toronto, Ontario / October 25-29, 2008
Toronto - Gaps between lipid targets set by guidelines and levels achieved in clinical practice continue to be reported, at least in part because targets for high-risk patients are difficult to achieve with well-tolerated doses of statin...
Canadian Cardiovascular Congress
ACE Inhibitors and ARBs: Compelling Evidence for Rational Comparison Now Available
Toronto, Ontario / October 25-29, 2008
Toronto - Until recently, the debate about the relative value of ACE inhibitors and angiotensin receptor blockers in cardiovascular (CV) risk management has been largely hypothetical. Although both inhibit the renin-angiotensin system (RAS)...
Canadian Cardiovascular Congress
The Pre-emptive Attack: Screening Cardiovascular Patients for Vulnerable Plaque
Toronto, Ontario / October 25-29, 2008
Toronto - Rapid advances in understanding the cascade of molecular and cellular events that culminate in myocardial infarction,stroke, and other thrombotic events suggest it will be increasingly possible to screen atherosclerotic lesions...
PHYSICIAN PERSPECTIVE Viewpoint based on presentations during the Canadian Cardiovascular Conference 2008
Advances in Antiplatelet Therapy
Toronto, Ontario / October 25-29, 2008
INTRODUCTION The introduction of antiplatelet therapy was a key development in the management of patients with acute coronary syndromes (ACS) and stroke. Antiplatelet therapy with ASA and clopidogrel is now considered a cornerstone of...